Treatment of nerve gas poisoning.
D000927:Anticonvulsants / Q000627:therapeutic use; D000931:Antidotes / Q000627:therapeutic use; D001285:Atropine / Q000627:therapeutic use; D002619:Chemical Warfare Agents / Q000506:poisoning*; D002800:Cholinesterase Inhibitors / Q000506:poisoning*; D005740:Gases; D006801:Humans; D062025:Organophosphate Poisoning; D010755:Organophosphates; D009946:Organothiophosphorus Compounds / Q000506:poisoning; D011220:Pralidoxime Compounds / Q000627:therapeutic use; D011729:Pyridostigmine Bromide / Q000627:therapeutic use; D012134:Respiratory Protective Devices; D012524:Sarin / Q000506:poisoning; D012999:Soman / Q000506:poisoning
D000927:Anticonvulsants; D000931:Antidotes; D001285:Atropine; D002619:Chemical Warfare Agents; D002800:Cholinesterase Inhibitors; D005740:Gases; D010755:Organophosphates; D009946:Organothiophosphorus Compounds; D011220:Pralidoxime Compounds; D011729:Pyridostigmine Bromide; D012524:Sarin; D012999:Soman; C009680:VX-agent; C028797:pralidoxime; C009374:tabun